APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mesalamine API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mesalamine API Industry Growth and Trends Forecast to 2032

Report ID 173307520128 December 2025109 pages

Choose your research edition.

Industry ResearchMesalamine API Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalamine API Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Mesalamine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalamine API Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalamine API Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Mesalamine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mesalamine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mesalamine API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mesalamine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mesalamine API include Cambrex Corporation, Chemi SpA, Corden Pharma Bergamo, CTX Lifescience, Divis Laboratories, Erregierre SpA, Ipca Laboratories, Ishita Active Pharma Ingredients and Lasa Loboratory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mesalamine API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mesalamine API market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mesalamine API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mesalamine API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mesalamine API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mesalamine API Market by Company

Cambrex Corporation

Chemi SpA

Corden Pharma Bergamo

CTX Lifescience

Divis Laboratories

Erregierre SpA

Ipca Laboratories

Ishita Active Pharma Ingredients

Lasa Loboratory

PharmaZell

Syntese A/S

Hangzhou Brother

Lianyungang Fengheng Biopharm

YC Biotech (Jiangsu)

Mesalamine API Segment by Type

Purity ≥ 99%

Purity ≥ 98%

Purity ≥ 97%

Mesalamine API Segment by Application

Suppository

Tablets

Granule

Capsules

Enema

Others

Mesalamine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalamine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalamine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalamine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mesalamine API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mesalamine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity ≥ 99% Table 2. Major Company of Purity ≥ 98% Table 3. Major Company of Purity ≥ 97% Table 4. Global Mesalamine API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Mesalamine API Sales by Type (2021-2026) & (t) Table 6. Global Mesalamine API Sales Market Share in Volume by Type (2021-2026) Table 7. Global Mesalamine API Sales by Type (2021-2026) & (US$ Million) Table 8. Global Mesalamine API Sales Market Share in Value by Type (2021-2026) Table 9. Global Mesalamine API Price by Type (2021-2026) & (USD/kg) Table 10. Global Mesalamine API Sales by Type (2027-2032) & (t) Table 11. Global Mesalamine API Sales Market Share in Volume by Type (2027-2032) Table 12. Global Mesalamine API Sales by Type (2027-2032) & (US$ Million) Table 13. Global Mesalamine API Sales Market Share in Value by Type (2027-2032) Table 14. Global Mesalamine API Price by Type (2027-2032) & (USD/kg) Table 15. North America Mesalamine API Sales by Type (2021-2026) & (t) Table 16. North America Mesalamine API Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Mesalamine API Sales by Type (2021-2026) & (t) Table 18. Europe Mesalamine API Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Mesalamine API Sales by Type (2021-2026) & (t) Table 20. Asia-Pacific Mesalamine API Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Mesalamine API Sales by Type (2021-2026) & (t) Table 22. Latin America Mesalamine API Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Mesalamine API Sales by Type (2021-2026) & (t) Table 24. Middle East and Africa Mesalamine API Sales by Type (2021-2026) & (US$ Million) Table 25. Mesalamine API Industry Trends Table 26. Mesalamine API Industry Drivers Table 27. Mesalamine API Industry Opportunities and Challenges Table 28. Mesalamine API Industry Restraints Table 29. Global Mesalamine API Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Mesalamine API Revenue Market Share by Company (2021-2026) Table 31. Global Mesalamine API Sales by Company (2021-2026) & (t) Table 32. Global Mesalamine API Sales Share by Company (2021-2026) Table 33. Global Mesalamine API Market Price by Company (2021-2026) & (USD/kg) Table 34. Global Mesalamine API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Mesalamine API Major Company Production Sites and Headquarters Table 36. Global Mesalamine API Company, Product Type & Application Table 37. Global Mesalamine API Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Mesalamine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Mesalamine API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Mesalamine API Sales by Region (2021-2026) & (t) Table 42. Global Mesalamine API Sales Market Share in Volume by Region (2021-2026) Table 43. Global Mesalamine API Sales by Region (2021-2026) & (US$ Million) Table 44. Global Mesalamine API Sales Market Share in Value by Region (2021-2026) Table 45. Global Mesalamine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 46. Global Mesalamine API Sales by Region (2027-2032) & (t) Table 47. Global Mesalamine API Sales Market Share in Volume by Region (2027-2032) Table 48. Global Mesalamine API Sales by Region (2027-2032) & (US$ Million) Table 49. Global Mesalamine API Sales Market Share in Value by Region (2027-2032) Table 50. Global Mesalamine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 51. Global Mesalamine API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Mesalamine API Sales by Application (2021-2026) & (t) Table 53. Global Mesalamine API Sales Market Share in Volume by Application (2021-2026) Table 54. Global Mesalamine API Sales by Application (2021-2026) & (US$ Million) Table 55. Global Mesalamine API Sales Market Share in Value by Application (2021-2026) Table 56. Global Mesalamine API Price by Application (2021-2026) & (USD/kg) Table 57. Global Mesalamine API Sales by Application (2027-2032) & (t) Table 58. Global Mesalamine API Sales Market Share in Volume by Application (2027-2032) Table 59. Global Mesalamine API Sales by Application (2027-2032) & (US$ Million) Table 60. Global Mesalamine API Sales Market Share in Value by Application (2027-2032) Table 61. Global Mesalamine API Price by Application (2027-2032) & (USD/kg) Table 62. North America Mesalamine API Sales by Application (2021-2026) & (t) Table 63. North America Mesalamine API Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Mesalamine API Sales by Application (2021-2026) & (t) Table 65. Europe Mesalamine API Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Mesalamine API Sales by Application (2021-2026) & (t) Table 67. Asia-Pacific Mesalamine API Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Mesalamine API Sales by Application (2021-2026) & (t) Table 69. Latin America Mesalamine API Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Mesalamine API Sales by Application (2021-2026) & (t) Table 71. Middle East and Africa Mesalamine API Sales by Application (2021-2026) & (US$ Million) Table 72. Cambrex Corporation Company Information Table 73. Cambrex Corporation Business Overview Table 74. Cambrex Corporation Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 75. Cambrex Corporation Mesalamine API Product Portfolio Table 76. Cambrex Corporation Recent Development Table 77. Chemi SpA Company Information Table 78. Chemi SpA Business Overview Table 79. Chemi SpA Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 80. Chemi SpA Mesalamine API Product Portfolio Table 81. Chemi SpA Recent Development Table 82. Corden Pharma Bergamo Company Information Table 83. Corden Pharma Bergamo Business Overview Table 84. Corden Pharma Bergamo Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 85. Corden Pharma Bergamo Mesalamine API Product Portfolio Table 86. Corden Pharma Bergamo Recent Development Table 87. CTX Lifescience Company Information Table 88. CTX Lifescience Business Overview Table 89. CTX Lifescience Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 90. CTX Lifescience Mesalamine API Product Portfolio Table 91. CTX Lifescience Recent Development Table 92. Divis Laboratories Company Information Table 93. Divis Laboratories Business Overview Table 94. Divis Laboratories Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 95. Divis Laboratories Mesalamine API Product Portfolio Table 96. Divis Laboratories Recent Development Table 97. Erregierre SpA Company Information Table 98. Erregierre SpA Business Overview Table 99. Erregierre SpA Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 100. Erregierre SpA Mesalamine API Product Portfolio Table 101. Erregierre SpA Recent Development Table 102. Ipca Laboratories Company Information Table 103. Ipca Laboratories Business Overview Table 104. Ipca Laboratories Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 105. Ipca Laboratories Mesalamine API Product Portfolio Table 106. Ipca Laboratories Recent Development Table 107. Ishita Active Pharma Ingredients Company Information Table 108. Ishita Active Pharma Ingredients Business Overview Table 109. Ishita Active Pharma Ingredients Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 110. Ishita Active Pharma Ingredients Mesalamine API Product Portfolio Table 111. Ishita Active Pharma Ingredients Recent Development Table 112. Lasa Loboratory Company Information Table 113. Lasa Loboratory Business Overview Table 114. Lasa Loboratory Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 115. Lasa Loboratory Mesalamine API Product Portfolio Table 116. Lasa Loboratory Recent Development Table 117. PharmaZell Company Information Table 118. PharmaZell Business Overview Table 119. PharmaZell Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 120. PharmaZell Mesalamine API Product Portfolio Table 121. PharmaZell Recent Development Table 122. Syntese A/S Company Information Table 123. Syntese A/S Business Overview Table 124. Syntese A/S Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 125. Syntese A/S Mesalamine API Product Portfolio Table 126. Syntese A/S Recent Development Table 127. Hangzhou Brother Company Information Table 128. Hangzhou Brother Business Overview Table 129. Hangzhou Brother Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 130. Hangzhou Brother Mesalamine API Product Portfolio Table 131. Hangzhou Brother Recent Development Table 132. Lianyungang Fengheng Biopharm Company Information Table 133. Lianyungang Fengheng Biopharm Business Overview Table 134. Lianyungang Fengheng Biopharm Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 135. Lianyungang Fengheng Biopharm Mesalamine API Product Portfolio Table 136. Lianyungang Fengheng Biopharm Recent Development Table 137. YC Biotech (Jiangsu) Company Information Table 138. YC Biotech (Jiangsu) Business Overview Table 139. YC Biotech (Jiangsu) Mesalamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 140. YC Biotech (Jiangsu) Mesalamine API Product Portfolio Table 141. YC Biotech (Jiangsu) Recent Development Table 142. North America Mesalamine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 143. North America Mesalamine API Sales by Country (2021-2026) & (t) Table 144. North America Mesalamine API Sales Market Share by Country (2021-2026) Table 145. North America Mesalamine API Sales Forecast by Country (2027-2032) & (t) Table 146. North America Mesalamine API Sales Market Share Forecast by Country (2027-2032) Table 147. North America Mesalamine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Mesalamine API Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Mesalamine API Market Share by Country (2021-2026) Table 150. North America Mesalamine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Mesalamine API Market Share Forecast by Country (2027-2032) Table 152. Europe Mesalamine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 153. Europe Mesalamine API Sales by Country (2021-2026) & (t) Table 154. Europe Mesalamine API Sales Market Share by Country (2021-2026) Table 155. Europe Mesalamine API Sales Forecast by Country (2027-2032) & (t) Table 156. Europe Mesalamine API Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Mesalamine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Mesalamine API Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Mesalamine API Market Share by Country (2021-2026) Table 160. Europe Mesalamine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Mesalamine API Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Mesalamine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Mesalamine API Sales by Country (2021-2026) & (t) Table 164. Asia-Pacific Mesalamine API Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Mesalamine API Sales Forecast by Country (2027-2032) & (t) Table 166. Asia-Pacific Mesalamine API Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Mesalamine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Mesalamine API Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Mesalamine API Market Share by Country (2021-2026) Table 170. Asia-Pacific Mesalamine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Mesalamine API Market Share Forecast by Country (2027-2032) Table 172. Latin America Mesalamine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 173. Latin America Mesalamine API Sales by Country (2021-2026) & (t) Table 174. Latin America Mesalamine API Sales Market Share by Country (2021-2026) Table 175. Latin America Mesalamine API Sales Forecast by Country (2027-2032) & (t) Table 176. Latin America Mesalamine API Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Mesalamine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Mesalamine API Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Mesalamine API Market Share by Country (2021-2026) Table 180. Latin America Mesalamine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Mesalamine API Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Mesalamine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Mesalamine API Sales by Country (2021-2026) & (t) Table 184. Middle East and Africa Mesalamine API Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Mesalamine API Sales Forecast by Country (2027-2032) & (t) Table 186. Middle East and Africa Mesalamine API Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Mesalamine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Mesalamine API Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Mesalamine API Market Share by Country (2021-2026) Table 190. Middle East and Africa Mesalamine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Mesalamine API Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Mesalamine API Distributors List Table 195. Mesalamine API Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Mesalamine API Image Figure 2. Global Mesalamine API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalamine API Market Size (2021-2032) & (US$ Million) Figure 4. Global Mesalamine API Sales (2021-2032) & (t) Figure 5. Purity ≥ 99% Image Figure 6. Global Purity ≥ 99% Sales YoY Growth (2021-2032) & (t) Figure 7. Purity ≥ 98% Image Figure 8. Global Purity ≥ 98% Sales YoY Growth (2021-2032) & (t) Figure 9. Purity ≥ 97% Image Figure 10. Global Purity ≥ 97% Sales YoY Growth (2021-2032) & (t) Figure 11. Global Mesalamine API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Mesalamine API Market Share by Type 2025 VS 2032 Figure 13. North America Mesalamine API Sales Market Share in Volume by Type in 2025 Figure 14. North America Mesalamine API Sales Market Share in Value by Type in 2025 Figure 15. Europe Mesalamine API Sales Market Share in Volume by Type in 2025 Figure 16. Europe Mesalamine API Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Mesalamine API Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Mesalamine API Sales Market Share in Value by Type in 2025 Figure 19. Latin America Mesalamine API Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Mesalamine API Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Mesalamine API Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Mesalamine API Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Mesalamine API Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Suppository Image Figure 26. Global Suppository Sales YoY Growth (2021-2032) & (t) Figure 27. Tablets Image Figure 28. Global Tablets Sales YoY Growth (2021-2032) & (t) Figure 29. Granule Image Figure 30. Global Granule Sales YoY Growth (2021-2032) & (t) Figure 31. Capsules Image Figure 32. Global Capsules Sales YoY Growth (2021-2032) & (t) Figure 33. Enema Image Figure 34. Global Enema Sales YoY Growth (2021-2032) & (t) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (t) Figure 37. Global Mesalamine API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Mesalamine API Market Share by Application 2025 VS 2032 Figure 39. North America Mesalamine API Sales Market Share in Volume by Application in 2025 Figure 40. North America Mesalamine API Sales Market Share in Value by Application in 2025 Figure 41. Europe Mesalamine API Sales Market Share in Volume by Application in 2025 Figure 42. Europe Mesalamine API Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Mesalamine API Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Mesalamine API Sales Market Share in Value by Application in 2025 Figure 45. Latin America Mesalamine API Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Mesalamine API Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Mesalamine API Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Mesalamine API Sales Market Share in Value by Application in 2025 Figure 49. North America Mesalamine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. North America Mesalamine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Mesalamine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Mesalamine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Mesalamine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Europe Mesalamine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Mesalamine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Mesalamine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Mesalamine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Asia-Pacific Mesalamine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Mesalamine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Mesalamine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Mesalamine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 62. Latin America Mesalamine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Mesalamine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Mesalamine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Mesalamine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 66. Middle East and Africa Mesalamine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Mesalamine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Mesalamine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Mesalamine API Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Mesalamine API Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 99%
  • Purity ≥ 98%
  • Purity ≥ 97%
Applications
  • Suppository
  • Tablets
  • Granule
  • Capsules
  • Enema
  • Others
Companies covered
  • Cambrex Corporation
  • Chemi SpA
  • Corden Pharma Bergamo
  • CTX Lifescience
  • Divis Laboratories
  • Erregierre SpA
  • Ipca Laboratories
  • Ishita Active Pharma Ingredients
  • Lasa Loboratory
  • PharmaZell
  • Syntese A/S
  • Hangzhou Brother
  • Lianyungang Fengheng Biopharm
  • YC Biotech (Jiangsu)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalamine API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mesalamine API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mesalamine API Market by Type
  6. 1.3.1 Purity ≥ 99%
  7. 1.3.2 Purity ≥ 98%
  8. 1.3.3 Purity ≥ 97%
  9. 1.4 Global Mesalamine API Market Size by Type
  10. 1.4.1 Global Mesalamine API Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Mesalamine API Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Mesalamine API Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Mesalamine API Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Mesalamine API Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Mesalamine API Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Mesalamine API Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Mesalamine API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mesalamine API Industry Trends
  2. 2.2 Mesalamine API Industry Drivers
  3. 2.3 Mesalamine API Industry Opportunities and Challenges
  4. 2.4 Mesalamine API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mesalamine API Revenue (2021-2026)
  2. 3.2 Global Top Players by Mesalamine API Sales (2021-2026)
  3. 3.3 Global Top Players by Mesalamine API Price (2021-2026)
  4. 3.4 Global Mesalamine API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesalamine API Major Company Production Sites & Headquarters
  6. 3.6 Global Mesalamine API Company, Product Type & Application
  7. 3.7 Global Mesalamine API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesalamine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesalamine API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mesalamine API Tier 1, Tier 2, and Tier 3
4 Mesalamine API Regional Status and Outlook
  1. 4.1 Global Mesalamine API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mesalamine API Historic Market Size by Region
  3. 4.2.1 Global Mesalamine API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mesalamine API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mesalamine API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mesalamine API Forecasted Market Size by Region
  7. 4.3.1 Global Mesalamine API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mesalamine API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mesalamine API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mesalamine API by Application
  1. 5.1 Mesalamine API Market by Application
  2. 5.1.1 Suppository
  3. 5.1.2 Tablets
  4. 5.1.3 Granule
  5. 5.1.4 Capsules
  6. 5.1.5 Enema
  7. 5.1.6 Others
  8. 5.2 Global Mesalamine API Market Size by Application
  9. 5.2.1 Global Mesalamine API Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Mesalamine API Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Mesalamine API Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Mesalamine API Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Mesalamine API Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Mesalamine API Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Mesalamine API Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Mesalamine API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cambrex Corporation
  2. 6.1.1 Cambrex Corporation Company Information
  3. 6.1.2 Cambrex Corporation Business Overview
  4. 6.1.3 Cambrex Corporation Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cambrex Corporation Mesalamine API Product Portfolio
  6. 6.1.5 Cambrex Corporation Recent Developments
  7. 6.2 Chemi SpA
  8. 6.2.1 Chemi SpA Company Information
  9. 6.2.2 Chemi SpA Business Overview
  10. 6.2.3 Chemi SpA Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chemi SpA Mesalamine API Product Portfolio
  12. 6.2.5 Chemi SpA Recent Developments
  13. 6.3 Corden Pharma Bergamo
  14. 6.3.1 Corden Pharma Bergamo Company Information
  15. 6.3.2 Corden Pharma Bergamo Business Overview
  16. 6.3.3 Corden Pharma Bergamo Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Corden Pharma Bergamo Mesalamine API Product Portfolio
  18. 6.3.5 Corden Pharma Bergamo Recent Developments
  19. 6.4 CTX Lifescience
  20. 6.4.1 CTX Lifescience Company Information
  21. 6.4.2 CTX Lifescience Business Overview
  22. 6.4.3 CTX Lifescience Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CTX Lifescience Mesalamine API Product Portfolio
  24. 6.4.5 CTX Lifescience Recent Developments
  25. 6.5 Divis Laboratories
  26. 6.5.1 Divis Laboratories Company Information
  27. 6.5.2 Divis Laboratories Business Overview
  28. 6.5.3 Divis Laboratories Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Divis Laboratories Mesalamine API Product Portfolio
  30. 6.5.5 Divis Laboratories Recent Developments
  31. 6.6 Erregierre SpA
  32. 6.6.1 Erregierre SpA Company Information
  33. 6.6.2 Erregierre SpA Business Overview
  34. 6.6.3 Erregierre SpA Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Erregierre SpA Mesalamine API Product Portfolio
  36. 6.6.5 Erregierre SpA Recent Developments
  37. 6.7 Ipca Laboratories
  38. 6.7.1 Ipca Laboratories Company Information
  39. 6.7.2 Ipca Laboratories Business Overview
  40. 6.7.3 Ipca Laboratories Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ipca Laboratories Mesalamine API Product Portfolio
  42. 6.7.5 Ipca Laboratories Recent Developments
  43. 6.8 Ishita Active Pharma Ingredients
  44. 6.8.1 Ishita Active Pharma Ingredients Company Information
  45. 6.8.2 Ishita Active Pharma Ingredients Business Overview
  46. 6.8.3 Ishita Active Pharma Ingredients Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ishita Active Pharma Ingredients Mesalamine API Product Portfolio
  48. 6.8.5 Ishita Active Pharma Ingredients Recent Developments
  49. 6.9 Lasa Loboratory
  50. 6.9.1 Lasa Loboratory Company Information
  51. 6.9.2 Lasa Loboratory Business Overview
  52. 6.9.3 Lasa Loboratory Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lasa Loboratory Mesalamine API Product Portfolio
  54. 6.9.5 Lasa Loboratory Recent Developments
  55. 6.10 PharmaZell
  56. 6.10.1 PharmaZell Company Information
  57. 6.10.2 PharmaZell Business Overview
  58. 6.10.3 PharmaZell Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 PharmaZell Mesalamine API Product Portfolio
  60. 6.10.5 PharmaZell Recent Developments
  61. 6.11 Syntese A/S
  62. 6.11.1 Syntese A/S Company Information
  63. 6.11.2 Syntese A/S Business Overview
  64. 6.11.3 Syntese A/S Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Syntese A/S Mesalamine API Product Portfolio
  66. 6.11.5 Syntese A/S Recent Developments
  67. 6.12 Hangzhou Brother
  68. 6.12.1 Hangzhou Brother Company Information
  69. 6.12.2 Hangzhou Brother Business Overview
  70. 6.12.3 Hangzhou Brother Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hangzhou Brother Mesalamine API Product Portfolio
  72. 6.12.5 Hangzhou Brother Recent Developments
  73. 6.13 Lianyungang Fengheng Biopharm
  74. 6.13.1 Lianyungang Fengheng Biopharm Company Information
  75. 6.13.2 Lianyungang Fengheng Biopharm Business Overview
  76. 6.13.3 Lianyungang Fengheng Biopharm Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Lianyungang Fengheng Biopharm Mesalamine API Product Portfolio
  78. 6.13.5 Lianyungang Fengheng Biopharm Recent Developments
  79. 6.14 YC Biotech (Jiangsu)
  80. 6.14.1 YC Biotech (Jiangsu) Company Information
  81. 6.14.2 YC Biotech (Jiangsu) Business Overview
  82. 6.14.3 YC Biotech (Jiangsu) Mesalamine API Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 YC Biotech (Jiangsu) Mesalamine API Product Portfolio
  84. 6.14.5 YC Biotech (Jiangsu) Recent Developments
7 North America by Country
  1. 7.1 North America Mesalamine API Sales by Country
  2. 7.1.1 North America Mesalamine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mesalamine API Sales by Country (2021-2026)
  4. 7.1.3 North America Mesalamine API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mesalamine API Market Size by Country
  6. 7.2.1 North America Mesalamine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mesalamine API Market Size by Country (2021-2026)
  8. 7.2.3 North America Mesalamine API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mesalamine API Sales by Country
  2. 8.1.1 Europe Mesalamine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mesalamine API Sales by Country (2021-2026)
  4. 8.1.3 Europe Mesalamine API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mesalamine API Market Size by Country
  6. 8.2.1 Europe Mesalamine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mesalamine API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mesalamine API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mesalamine API Sales by Country
  2. 9.1.1 Asia-Pacific Mesalamine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mesalamine API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mesalamine API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mesalamine API Market Size by Country
  6. 9.2.1 Asia-Pacific Mesalamine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mesalamine API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mesalamine API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mesalamine API Sales by Country
  2. 10.1.1 South America Mesalamine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mesalamine API Sales by Country (2021-2026)
  4. 10.1.3 South America Mesalamine API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mesalamine API Market Size by Country
  6. 10.2.1 South America Mesalamine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mesalamine API Market Size by Country (2021-2026)
  8. 10.2.3 South America Mesalamine API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mesalamine API Sales by Country
  2. 11.1.1 Middle East and Africa Mesalamine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mesalamine API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mesalamine API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mesalamine API Market Size by Country
  6. 11.2.1 Middle East and Africa Mesalamine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mesalamine API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mesalamine API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mesalamine API Value Chain Analysis
  2. 12.1.1 Mesalamine API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mesalamine API Production Mode & Process
  7. 12.2 Mesalamine API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mesalamine API Distributors
  10. 12.2.3 Mesalamine API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst